Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes

Highly potent neutralizing nanobodies (Nbs) are of great interest as potential COVID-19 therapeutics. Here, the authors show that potent neutralizing Nbs targeting the receptor binding domain (RBD) of the SARS-CoV-2 spike protein are also effective against convergent variants of concern of the virus...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dapeng Sun, Zhe Sang, Yong Joon Kim, Yufei Xiang, Tomer Cohen, Anna K. Belford, Alexis Huet, James F. Conway, Ji Sun, Derek J. Taylor, Dina Schneidman-Duhovny, Cheng Zhang, Wei Huang, Yi Shi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/98aa4a733c5b42fb84aa2005c4550187
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:98aa4a733c5b42fb84aa2005c4550187
record_format dspace
spelling oai:doaj.org-article:98aa4a733c5b42fb84aa2005c45501872021-12-02T16:35:42ZPotent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes10.1038/s41467-021-24963-32041-1723https://doaj.org/article/98aa4a733c5b42fb84aa2005c45501872021-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24963-3https://doaj.org/toc/2041-1723Highly potent neutralizing nanobodies (Nbs) are of great interest as potential COVID-19 therapeutics. Here, the authors show that potent neutralizing Nbs targeting the receptor binding domain (RBD) of the SARS-CoV-2 spike protein are also effective against convergent variants of concern of the virus. They determine eight Nb-bound spike protein cryo-EM structures, classify the binding epitopes of the Nbs and discuss their neutralization mechanisms.Dapeng SunZhe SangYong Joon KimYufei XiangTomer CohenAnna K. BelfordAlexis HuetJames F. ConwayJi SunDerek J. TaylorDina Schneidman-DuhovnyCheng ZhangWei HuangYi ShiNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Dapeng Sun
Zhe Sang
Yong Joon Kim
Yufei Xiang
Tomer Cohen
Anna K. Belford
Alexis Huet
James F. Conway
Ji Sun
Derek J. Taylor
Dina Schneidman-Duhovny
Cheng Zhang
Wei Huang
Yi Shi
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
description Highly potent neutralizing nanobodies (Nbs) are of great interest as potential COVID-19 therapeutics. Here, the authors show that potent neutralizing Nbs targeting the receptor binding domain (RBD) of the SARS-CoV-2 spike protein are also effective against convergent variants of concern of the virus. They determine eight Nb-bound spike protein cryo-EM structures, classify the binding epitopes of the Nbs and discuss their neutralization mechanisms.
format article
author Dapeng Sun
Zhe Sang
Yong Joon Kim
Yufei Xiang
Tomer Cohen
Anna K. Belford
Alexis Huet
James F. Conway
Ji Sun
Derek J. Taylor
Dina Schneidman-Duhovny
Cheng Zhang
Wei Huang
Yi Shi
author_facet Dapeng Sun
Zhe Sang
Yong Joon Kim
Yufei Xiang
Tomer Cohen
Anna K. Belford
Alexis Huet
James F. Conway
Ji Sun
Derek J. Taylor
Dina Schneidman-Duhovny
Cheng Zhang
Wei Huang
Yi Shi
author_sort Dapeng Sun
title Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
title_short Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
title_full Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
title_fullStr Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
title_full_unstemmed Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
title_sort potent neutralizing nanobodies resist convergent circulating variants of sars-cov-2 by targeting diverse and conserved epitopes
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/98aa4a733c5b42fb84aa2005c4550187
work_keys_str_mv AT dapengsun potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT zhesang potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT yongjoonkim potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT yufeixiang potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT tomercohen potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT annakbelford potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT alexishuet potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT jamesfconway potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT jisun potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT derekjtaylor potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT dinaschneidmanduhovny potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT chengzhang potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT weihuang potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
AT yishi potentneutralizingnanobodiesresistconvergentcirculatingvariantsofsarscov2bytargetingdiverseandconservedepitopes
_version_ 1718383707650260992